PARP1 promotes EGFR-TKI drug-resistance via PI3K/AKT pathway in non-small-cell lung cancer Xianping Xu,Yu Liu,Qiang Gong,Le Ma,Wei Wei, Linqiong Zhao,Zhibin LuoCancer Chemotherapy and Pharmacology（2024）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
